Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
TAK Biopharma IVS
IVS
In liquidation
Advertising protection
CVR 37962872
Ole Maaløes Vej 3, 2200
København N
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2016 · 9 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
TAK Biopharma IVS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
0M
-1M
-1M
2016: 0M
0M
2016
2017: 0M
0M
2017
2018: 0M
0M
2018
2019: 0M
0M
2019
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2016: 0M
0M
2016
2017: 0M
0M
2017
2018: 0M
0M
2018
2019: 0M
0M
2019
Income statement
DKK thousands
Item
2019
2018
2017
2016
Revenue
380
206
80
0
Staff expenses
-322
-0
-70
-142
EBITDA
-22
149
-23
-158
Depreciation & amort.
-0
-0
-0
-0
EBIT
-22
149
-23
-158
Net financials
-0
-0
-0
0
Profit before tax
-22
149
-23
-158
Tax
-0
-0
-0
-0
Net profit
-22
149
-23
-158
Balance sheet
DKK thousands
Item
2019
2018
2017
2016
Total assets
70
16
1
24
Equity
-60
-38
-187
-157
Long-term debt
0
0
144
130
Short-term debt
130
54
43
52
Total debt
130
54
188
182
Financial ratios
5-year trend
EBITDA margin
-5,8 %
This company
15,8 %
Market median
This company
Market median
137% below market
2016
2019
Equity ratio
-84,9 %
This company
38,2 %
Market median
This company
Market median
322% below market
2016
2019
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2016
2019
Net profit margin
-5,8 %
This company
8,1 %
Market median
This company
Market median
172% below market
2016
2019
Asset turnover
5,40×
This company
1,12×
Market median
This company
Market median
382% above market
2016
2019
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2016
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-08-26 – 2016-12-31
View
PDF
More on TAK Biopharma IVS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
